Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Health insurance claims and electronic health records (EHR) databases have been considered the preferred data sources with which to study drug safety and effectiveness in routine care. Linking claims data to EHR allows researchers to leverage the complementary advantages of each data source to enhance study validity. We propose a framework to evaluate the need for supplementing claims data with EHR and vice versa to optimize outcome ascertainment, exposure assessment, and confounding adjustment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
Büller (2012) · doi:10.1056/nejmoa1113572 · Cited by 2,353
Dewilde, W. J., Oirbans, T., Verheugt, F. W., Kelder, J. C., De Smet, B. J., Herrman, J.-P., Adriaenssens, T., Vrolix, M., Heestermans, A. A., Vis, M. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62177-1 · Cited by 1,719 · cited 1×
“An example of an illustrative clinical question would be to investigate the comparative safety and effectiveness of different antithrombotic regimens (oral anticoagulants [OAC] with/without additional antiplatelet agents where information on aspirin requires EHRs) for chronic OAC users after a new myocardial infarctio…”
BackgroundWhy we need observational studies to evaluate the effectiveness of health care
Black, N. (1996) · BMJ · doi:10.1136/bmj.312.7040.1215 · Cited by 1,598 · cited 1×
“However, they are often considered of limited value for decision making in routine care, because: 1) data derived from a selected population in clinical trials often fail to translate into effectiveness and safety profiles for patients encountered in routine practice, which include a more vulnerable population with a…”
BackgroundRepresentation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat, A., Gross, C. P., & Krumholz, H. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1682 · Cited by 723 · cited 1×
“However, they are often considered of limited value for decision making in routine care, because: 1) data derived from a selected population in clinical trials often fail to translate into effectiveness and safety profiles for patients encountered in routine practice, which include a more vulnerable population with a…”
BackgroundLewis, J. D., Schinnar, R., Bilker, W. B., Wang, X., & Strom, B. L. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1335 · Cited by 602
Catheter ablation for atrial fibrillation in patients with obesity
Cha, Y.-M., Friedman, P. A., Asirvatham, S. J., Shen, W.-K., Munger, T. M., Rea, R. F., Brady, P. A., Jahangir, A., Monahan, K. H., Hodge, D. O., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.716712 · Cited by 110
Cited by
When and how can real world data analyses substitute for randomized controlled trials?
Franklin, J. M., & Schneeweiss, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.857 · Cited by 316
Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
Wharton, S., Liu, A., Pakseresht, A., Nørtoft, E., Haase, C. L., Mancini, J., Power, G. S., Vanderlelie, S., & Christensen, R. A. G. (2019) · Obesity · doi:10.1002/oby.22462 · Cited by 77
“Although these clinical trials offer a wealth of valuable information about safety and efficacy, the data derived from the highly controlled and specific population in the trials might not translate to a real-world setting (28).”
BackgroundInfluentialPark, J. H., Kim, J. Y., Choi, J. H., Park, H. S., Shin, H.-Y., Lee, J. M., Kim, J.-W., Ko, H.-J., Chon, S., Kim, B. K., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00739-z · Cited by 48
Park, J. S., Kwon, J., Choi, H. J., & Lee, C. (2021) · Medicine · doi:10.1097/md.0000000000023780 · Cited by 27
Oral, A., Küçük, C., & Köse, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206121 · Cited by 8
“In a real-world setting, patients are subject to a greater number of uncontrolled variables and often experience a wider range of comorbidities and variable adherence to treatment, which can impact the efficacy of the drug in this context [14].”
Background
Metadata
- Authors
- Lin, K., & Schneeweiss, S.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2016-05-12
- Volume
- 100
- Issue
- 2
- Pages
- 147-159
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2338171581
- Cited by
- 75
- References
- 8
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.